Myricetin 3-O-galactosideCAS# 15648-86-9 |
2D Structure
- Myricetin 3-O-beta-D-glucopyranoside
Catalog No.:BCN8144
CAS No.:19833-12-6
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 15648-86-9 | SDF | Download SDF |
PubChem ID | 5491408 | Appearance | Yellow powder |
Formula | C21H20O13 | M.Wt | 480.38 |
Type of Compound | Flavonoids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | 5,7-dihydroxy-3-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-(3,4,5-trihydroxyphenyl)chromen-4-one | ||
SMILES | C1=C(C=C(C(=C1O)O)O)C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)OC4C(C(C(C(O4)CO)O)O)O | ||
Standard InChIKey | FOHXFLPXBUAOJM-MGMURXEASA-N | ||
Standard InChI | InChI=1S/C21H20O13/c22-5-12-15(28)17(30)18(31)21(33-12)34-20-16(29)13-8(24)3-7(23)4-11(13)32-19(20)6-1-9(25)14(27)10(26)2-6/h1-4,12,15,17-18,21-28,30-31H,5H2/t12-,15+,17+,18-,21+/m1/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | Myricetin 3-O-galactoside has cytotoxicity, antioxidant, anti-genotoxic, antinociceptive and anti-inflammatory effects, the effects are related to peripheral inhibition of nitric oxide synthesis, mainly inducible nitric oxide synthase (iNOS). |
Targets | PARP | NOS | NO |
In vitro | In vitro antioxidant and antigenotoxic potentials of myricetin-3-o-galactoside and myricetin-3-o-rhamnoside from Myrtus communis: modulation of expression of genes involved in cell defence system using cDNA microarray.[Pubmed: 18222061]Toxicol In Vitro. 2008 Apr;22(3):567-81.Antioxidant activity of Myricetin 3-O-galactoside and myricetin-3-o-rhamnoside, isolated from the leaves of Myrtus communis, was determined by the ability of each compound to inhibit xanthine oxidase activity, lipid peroxidation and to scavenge the free radical 1,1-diphenyl-2-picrylhydrazyl. |
In vivo | Betula pendula Roth leaves: gastroprotective effects of an HPLC-fingerprinted methanolic extract.[Pubmed: 23163340]Nat Prod Res. 2013;27(17):1569-75.In this study, a methanolic extract of Betula pendula leaves (BLE) was investigated for its gastroprotective effects against 90% ethanol-induced ulcer in rats. Cytotoxicity and Suppressive Effect of Leaves of Mimusops laurifolia on Carbon Tetrachloride-induced Liver Injury in Rats and its Bioactive Constituents[Reference: WebLink]Asian Journal of Plant Sciences, 2012, 11(3): 124-30.Since the genus Mimusops is one of the important genera in the Indian traditional medicine, and is represented in Egypt with species; Mimusops laurifolia (Forssk.) Friis., thus the plant is selected for our investigation to reveal its biological activities and phytochemically analyze its bioactive fractions.
|
Animal Research | Antinociceptive and anti-inflammatory effects of myricetin 3-O-β-galactoside isolated from Davilla elliptica: involvement of the nitrergic system.[Pubmed: 25894075 ]J Nat Med. 2015 Jul;69(3):303-12.We aimed to study the antinociceptive effects of myricetin 3-O-β-galactoside (Myricetin 3-O-galactoside,Mi), a substance isolated from the hydroalcoholic extract of Davilla elliptica. |
Myricetin 3-O-galactoside Dilution Calculator
Myricetin 3-O-galactoside Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.0817 mL | 10.4084 mL | 20.8169 mL | 41.6337 mL | 52.0421 mL |
5 mM | 0.4163 mL | 2.0817 mL | 4.1634 mL | 8.3267 mL | 10.4084 mL |
10 mM | 0.2082 mL | 1.0408 mL | 2.0817 mL | 4.1634 mL | 5.2042 mL |
50 mM | 0.0416 mL | 0.2082 mL | 0.4163 mL | 0.8327 mL | 1.0408 mL |
100 mM | 0.0208 mL | 0.1041 mL | 0.2082 mL | 0.4163 mL | 0.5204 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- α-Conotoxin ImI
Catalog No.:BCC5974
CAS No.:156467-85-5
- cis-Khellactone
Catalog No.:BCN3703
CAS No.:15645-11-1
- CWHM-12
Catalog No.:BCC5548
CAS No.:1564286-55-0
- 3,4-Seco-3-oxobisabol-10-ene-4,1-olide
Catalog No.:BCN7550
CAS No.:1564265-85-5
- Ailanthoidol
Catalog No.:BCN7705
CAS No.:156398-61-7
- Ehretioside B
Catalog No.:BCN1703
CAS No.:156368-84-2
- 11-Anhydro-16-oxoalisol A
Catalog No.:BCN7703
CAS No.:156338-93-1
- PyAOP
Catalog No.:BCC2819
CAS No.:156311-83-0
- GTS 21 dihydrochloride
Catalog No.:BCC7948
CAS No.:156223-05-1
- Hispidulin 7-O-neohesperidoside
Catalog No.:BCN2952
CAS No.:156186-00-4
- CEP 1347
Catalog No.:BCC7982
CAS No.:156177-65-0
- Maackiaflavanone
Catalog No.:BCN6834
CAS No.:156162-10-6
- 1-Hydroxytropacocaine
Catalog No.:BCN1919
CAS No.:156497-23-3
- 7,13-Dideacetyl-9,10-didebenzoyltaxchinin C
Catalog No.:BCN7670
CAS No.:156497-25-5
- Ryanodine
Catalog No.:BCC5742
CAS No.:15662-33-6
- Cisplatin
Catalog No.:BCN1552
CAS No.:14283-03-5
- 1,2,5-Trihydroxyxanthone
Catalog No.:BCN7585
CAS No.:156640-23-2
- Org 20599
Catalog No.:BCC7470
CAS No.:156685-94-8
- Rostafuroxin (PST 2238)
Catalog No.:BCC6431
CAS No.:156722-18-8
- SNC 80
Catalog No.:BCC6785
CAS No.:156727-74-1
- Delphinidin-3-O-rutinoside chloride
Catalog No.:BCN3115
CAS No.:15674-58-5
- (RS)-(±)-Sulpiride
Catalog No.:BCC6835
CAS No.:15676-16-1
- Hosenkoside B
Catalog No.:BCN4584
CAS No.:156764-82-8
- Hosenkoside C
Catalog No.:BCN2632
CAS No.:156764-83-9
Antinociceptive and anti-inflammatory effects of myricetin 3-O-beta-galactoside isolated from Davilla elliptica: involvement of the nitrergic system.[Pubmed:25894075]
J Nat Med. 2015 Oct;69(4):487-93.
We aimed to study the antinociceptive effects of myricetin 3-O-beta-galactoside (Mi), a substance isolated from the hydroalcoholic extract of Davilla elliptica. This study examined male Swiss mice, inducible nitric oxide synthase C57B16/J knockout mice (iNOS(-/-)), and their corresponding wild type (WT). Formalin and tail-flick tests were used to evaluate the nociceptive threshold, and the carrageenan-induced paw edema test was used as a model for inflammation. The following drugs were administered to investigate the involvement of the nitrergic and opioidergic systems: L-NAME, a nonspecific nitric oxide synthase (NOS) inhibitor; L-arginine (L-Arg), a precursor for the synthesis of nitric oxide (NO); D-arginine (D-Arg), an inactive isomer for the synthesis of NO; aminoguanidine (Am), an inducible nitric oxide synthase (iNOS) inhibitor; and naloxone, a nonselective antagonist of opioid receptors. The results showed that oral pretreatment with Mi caused a dose-dependent inhibition of the inflammatory phase of the formalin test and did not alter motor performance. Intraperitoneal injection of L-NAME caused a reduction in the licking time during the second phase of the formalin test. The administration of L-Arg (but not D-Arg) reversed the antinociceptive effect of L-NAME. Furthermore, pre-administration of aminoguanidine potentiated the antinociceptive effect. Mi did not cause an antinociceptive effect in iNOS knockouts and led to a reduction in the nitrite concentration in the paws of mice. Carrageenan-induced paw edema was reduced in Swiss mice and WT mice when compared to iNOS(-/-) mice. Pre-administration of naloxone (NLX) did not reverse the antinociceptive effect of Mi, excluding the opioidergic system as a mediator of the antinociceptive effect. Thus, the results suggest that the antinociceptive and anti-inflammatory effects of myricetin 3-O-beta-galactoside are related to peripheral inhibition of nitric oxide synthesis, mainly iNOS.
In vitro antioxidant and antigenotoxic potentials of myricetin-3-o-galactoside and myricetin-3-o-rhamnoside from Myrtus communis: modulation of expression of genes involved in cell defence system using cDNA microarray.[Pubmed:18222061]
Toxicol In Vitro. 2008 Apr;22(3):567-81.
Antioxidant activity of myricetin-3-o-galactoside and myricetin-3-o-rhamnoside, isolated from the leaves of Myrtus communis, was determined by the ability of each compound to inhibit xanthine oxidase activity, lipid peroxidation and to scavenge the free radical 1,1-diphenyl-2-picrylhydrazyl. Antimutagenic activity was assessed using the SOS chromotest and the Comet assay. The IC50 values of lipid peroxidation by myricetin-3-o-galactoside and myricetin-3-o-rhamnoside are respectively 160 microg/ml and 220 microg/ml. At a concentration of 100 microg/ml, the two compounds showed the most potent inhibitory effect of xanthine oxidase activity by respectively, 57% and 59%. Myricetin-3-o-rhamnoside was a very potent radical scavenger with an IC50 value of 1.4 microg/ml. Moreover, these two compounds induced an inhibitory activity against nifuroxazide, aflatoxine B1 and H2O2 induced mutagenicity. The protective effect exhibited by these molecules was also determined by analysis of gene expression as response to an oxidative stress using a cDNA micro-array. Myricetin-3-o-galactoside and myricetin-3-o-rhamnoside modulated the expression patterns of cellular genes involved in oxidative stress, respectively (GPX1, TXN, AOE372, SEPW1, SHC1) and (TXNRD1, TXN, SOD1 AOE372, SEPW1), in DNA damaging repair, respectively (XPC, LIG4, RPA3, PCNA, DDIT3, POLD1, XRCC5, MPG) and (TDG, PCNA, LIG4, XRCC5, DDIT3, MSH2, ERCC5, RPA3, POLD1), and in apoptosis (PARP).
Betula pendula Roth leaves: gastroprotective effects of an HPLC-fingerprinted methanolic extract.[Pubmed:23163340]
Nat Prod Res. 2013;27(17):1569-75.
In this study, a methanolic extract of Betula pendula leaves (BLE) was investigated for its gastroprotective effects against 90% ethanol-induced ulcer in rats. Oral pretreatment of rats with BLE (100, 200 and 400 mg kg(- 1)) significantly reduced the incidence of gastric lesions induced by ethanol administration as compared with misoprostol (0.50 mg kg(- 1)). Furthermore, BLE inhibited the increase in malondialdehyde (MDA) and prevented depletion of total sulhydryl and non-protein sulhydryl groups in rat stomach homogenate when compared with ethanol group. With regard to the effect of lipid peroxidation in vitro, BLE showed the ability to reduce methyl linoleate autoxidation. Chemical characterisation of the main biologically active constituents of BLE was also achieved by means of high-performance liquid chromatography with photodiode array and mass spectrometry detection, showing the presence of myricetin-3-O-galactoside, quercetin glycosides, kaempferol glycosides.